Inhibition of Alzheimer β-fibrillogenesis by melatonin

Miguel Pappolla, Peter Bozner, Claudio Soto, Haiyan Shao, Nickolaos K. Robakis, Michael Zagorski, Blas Frangione, Jorge Ghiso

Research output: Contribution to journalArticle

274 Citations (Scopus)

Abstract

It is generally postulated that the amyloid β protein (Aβ) plays a central role in the progressive neurodegeneration observed in Alsheimer's disease. Important pathologic properties of this protein, such as neurotoxicity and resistance to proteolytic degradation, depend on the ability of Aβ to form β-sheet structures or amyloid fibrils. We report that melatonin a hormone recently found to protect neurons against Aβ toxicity, interacts with Aβ1-40 and Aβ1-42 and inhibits the progressive formation of β-sheets and amyloid fibrils. These interactions between melatonin and the amyloid peptides were demonstrated by circular dichroism and electron microscopy for Aβ1-40 and Aβ-42 and by nuclear magnetic resonance spectroscopy for Aβ1-40. Inhibition of β-sheets and fibrils could not be accomplished in control experiments when a free radical scavenger or a melatonin analog were substituted for melatonin under otherwise identical conditions. In sharp contrast with conventional anti-oxidants and available anti-amyloidogenic compounds, melatonin crosses the blood-brain barrier, is relatively devoid of toxicity, and constitutes a potential new therapeutic agent in Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)7185-7188
Number of pages4
JournalJournal of Biological Chemistry
Volume273
Issue number13
DOIs
StatePublished - Mar 27 1998
Externally publishedYes

Fingerprint

Melatonin
Amyloid
Toxicity
Serum Amyloid A Protein
Free Radical Scavengers
Aptitude
Circular Dichroism
Blood-Brain Barrier
Oxidants
Electron microscopy
Nuclear magnetic resonance spectroscopy
Neurons
Electron Microscopy
Alzheimer Disease
Magnetic Resonance Spectroscopy
Inhibition (Psychology)
Hormones
Degradation
Peptides
Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Pappolla, M., Bozner, P., Soto, C., Shao, H., Robakis, N. K., Zagorski, M., ... Ghiso, J. (1998). Inhibition of Alzheimer β-fibrillogenesis by melatonin. Journal of Biological Chemistry, 273(13), 7185-7188. https://doi.org/10.1074/jbc.273.13.7185

Inhibition of Alzheimer β-fibrillogenesis by melatonin. / Pappolla, Miguel; Bozner, Peter; Soto, Claudio; Shao, Haiyan; Robakis, Nickolaos K.; Zagorski, Michael; Frangione, Blas; Ghiso, Jorge.

In: Journal of Biological Chemistry, Vol. 273, No. 13, 27.03.1998, p. 7185-7188.

Research output: Contribution to journalArticle

Pappolla, M, Bozner, P, Soto, C, Shao, H, Robakis, NK, Zagorski, M, Frangione, B & Ghiso, J 1998, 'Inhibition of Alzheimer β-fibrillogenesis by melatonin', Journal of Biological Chemistry, vol. 273, no. 13, pp. 7185-7188. https://doi.org/10.1074/jbc.273.13.7185
Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M et al. Inhibition of Alzheimer β-fibrillogenesis by melatonin. Journal of Biological Chemistry. 1998 Mar 27;273(13):7185-7188. https://doi.org/10.1074/jbc.273.13.7185
Pappolla, Miguel ; Bozner, Peter ; Soto, Claudio ; Shao, Haiyan ; Robakis, Nickolaos K. ; Zagorski, Michael ; Frangione, Blas ; Ghiso, Jorge. / Inhibition of Alzheimer β-fibrillogenesis by melatonin. In: Journal of Biological Chemistry. 1998 ; Vol. 273, No. 13. pp. 7185-7188.
@article{b6ecbb132c15478baf451ae77c45988a,
title = "Inhibition of Alzheimer β-fibrillogenesis by melatonin",
abstract = "It is generally postulated that the amyloid β protein (Aβ) plays a central role in the progressive neurodegeneration observed in Alsheimer's disease. Important pathologic properties of this protein, such as neurotoxicity and resistance to proteolytic degradation, depend on the ability of Aβ to form β-sheet structures or amyloid fibrils. We report that melatonin a hormone recently found to protect neurons against Aβ toxicity, interacts with Aβ1-40 and Aβ1-42 and inhibits the progressive formation of β-sheets and amyloid fibrils. These interactions between melatonin and the amyloid peptides were demonstrated by circular dichroism and electron microscopy for Aβ1-40 and Aβ-42 and by nuclear magnetic resonance spectroscopy for Aβ1-40. Inhibition of β-sheets and fibrils could not be accomplished in control experiments when a free radical scavenger or a melatonin analog were substituted for melatonin under otherwise identical conditions. In sharp contrast with conventional anti-oxidants and available anti-amyloidogenic compounds, melatonin crosses the blood-brain barrier, is relatively devoid of toxicity, and constitutes a potential new therapeutic agent in Alzheimer's disease.",
author = "Miguel Pappolla and Peter Bozner and Claudio Soto and Haiyan Shao and Robakis, {Nickolaos K.} and Michael Zagorski and Blas Frangione and Jorge Ghiso",
year = "1998",
month = "3",
day = "27",
doi = "10.1074/jbc.273.13.7185",
language = "English (US)",
volume = "273",
pages = "7185--7188",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "13",

}

TY - JOUR

T1 - Inhibition of Alzheimer β-fibrillogenesis by melatonin

AU - Pappolla, Miguel

AU - Bozner, Peter

AU - Soto, Claudio

AU - Shao, Haiyan

AU - Robakis, Nickolaos K.

AU - Zagorski, Michael

AU - Frangione, Blas

AU - Ghiso, Jorge

PY - 1998/3/27

Y1 - 1998/3/27

N2 - It is generally postulated that the amyloid β protein (Aβ) plays a central role in the progressive neurodegeneration observed in Alsheimer's disease. Important pathologic properties of this protein, such as neurotoxicity and resistance to proteolytic degradation, depend on the ability of Aβ to form β-sheet structures or amyloid fibrils. We report that melatonin a hormone recently found to protect neurons against Aβ toxicity, interacts with Aβ1-40 and Aβ1-42 and inhibits the progressive formation of β-sheets and amyloid fibrils. These interactions between melatonin and the amyloid peptides were demonstrated by circular dichroism and electron microscopy for Aβ1-40 and Aβ-42 and by nuclear magnetic resonance spectroscopy for Aβ1-40. Inhibition of β-sheets and fibrils could not be accomplished in control experiments when a free radical scavenger or a melatonin analog were substituted for melatonin under otherwise identical conditions. In sharp contrast with conventional anti-oxidants and available anti-amyloidogenic compounds, melatonin crosses the blood-brain barrier, is relatively devoid of toxicity, and constitutes a potential new therapeutic agent in Alzheimer's disease.

AB - It is generally postulated that the amyloid β protein (Aβ) plays a central role in the progressive neurodegeneration observed in Alsheimer's disease. Important pathologic properties of this protein, such as neurotoxicity and resistance to proteolytic degradation, depend on the ability of Aβ to form β-sheet structures or amyloid fibrils. We report that melatonin a hormone recently found to protect neurons against Aβ toxicity, interacts with Aβ1-40 and Aβ1-42 and inhibits the progressive formation of β-sheets and amyloid fibrils. These interactions between melatonin and the amyloid peptides were demonstrated by circular dichroism and electron microscopy for Aβ1-40 and Aβ-42 and by nuclear magnetic resonance spectroscopy for Aβ1-40. Inhibition of β-sheets and fibrils could not be accomplished in control experiments when a free radical scavenger or a melatonin analog were substituted for melatonin under otherwise identical conditions. In sharp contrast with conventional anti-oxidants and available anti-amyloidogenic compounds, melatonin crosses the blood-brain barrier, is relatively devoid of toxicity, and constitutes a potential new therapeutic agent in Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=0032571381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032571381&partnerID=8YFLogxK

U2 - 10.1074/jbc.273.13.7185

DO - 10.1074/jbc.273.13.7185

M3 - Article

VL - 273

SP - 7185

EP - 7188

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 13

ER -